<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In general, the pathogenic strains exhibited low sensitivity to the tested probiotics, except to P5 (85% of sensitivity); 25, 15, 30, 5 and 15% of the strains were sensitive to P1, P2, P3 and P4, respectively (
 <xref rid="pone.0210478.t003" ref-type="table" class="xref">Table 3</xref>). Intermediate sensitivity was observed for 10, 5, 5, 10 and 15% of the strains to the probiotics P1, P2, P3, P4 and P5, respectively (
 <xref rid="pone.0210478.t003" ref-type="table" class="xref">Table 3</xref>). In terms of resistance, 65, 80, 65, 75 and 0% of the pathogenic strains were resistant to P1, P2, P3, P4 and P5, respectively (
 <xref rid="pone.0210478.t003" ref-type="table" class="xref">Table 3</xref>). Two isolates (L15.10.3 and L.15.10.4) were resistant or intermediate resistant to all tested probiotics (
 <xref rid="pone.0210478.t003" ref-type="table" class="xref">Table 3</xref>); strains L15.10.3 and L15.10.4 also presented the highest mortalities in the 
 <italic class="italic">P</italic>. 
 <italic class="italic">vannamei</italic> challenge test. The complete list of diameters of the inhibition halos is provided in 
 <xref ref-type="supplementary-material" rid="pone.0210478.s002" class="xref">S2 Table</xref>.
</p>
